Rethinking Go-to-Market From the Ground Up

AI is transforming how pharmaceutical companies approach go-to-market strategy, HCP engagement, and field team performance. But with new capabilities comes a critical question: What’s actually changing, and what’s just hype? In the debut episode of Open Label, Norstella’s AI podcast for pharma, host Kris Kaneta is joined by Omar Lansari of Citius Oncology and Allison […]
How Citius Oncology Used Norstella’s RWD Solutions to Fuel Commercial Triggers and Focus Field Engagement

For Citius Oncology, launching the drug Lymphir meant understanding where patients with cutaneous T-cell lymphoma (CTCL), a rare type of skin cancer, were receiving care, and helping its field team prioritize relevant providers and accounts. Citius partnered with Norstella to combine insights from integrated real-world data with a commercial triggers program. The ultimate solution provided […]
Identifying Rare Pediatric Cancer Patients With Real-World Data

A biopharma company used NorstellaLinQ to identify hard-to-find rare pediatric cancer patients, reaching beyond the limits of claims data to drive real-time demand for its rare oncology therapy. The company: Surfaced rare disease patients invisible in traditional claims data Delivered high-fidelity, near-real-time patient identification alerts to field teams Brought therapy to these patients and families […]
See the Full Bladder Cancer Journey. Not Just the Billing Codes.

For bladder cancer, claims data can’t tell you a patient’s stage, BCG status, or biomarker results. The detail you need lives in the physician’s notes. NorstellaLinQ not only extracts that data, but we go a step further by tapping specialists to confirm it. In this infographic, find out: How board-certified urologists and medical oncologists challenged […]
AI + Real-World Data: What the Next Five Years Look Like for Pharma

In the final episode of Real-World Data After Dark season 2, host Daniel Chancellor is joined by Norstella’s Kris Kaneta, Chief Product & Innovation Officer, and Ted Search, Chief Real-World Data & Analytics Officer, to explore what’s next for real-world data, artificial intelligence, and healthcare analytics. Looking beyond today’s AI capabilities, the conversation examines how […]
Stop Flying Blind. Start Targeting with Greater Precision.

NorstellaLinQ explores how integrated real-world data and AI-powered analytics help pharmaceutical commercial teams identify high-value patients, understand prescriber behavior and uncover emerging market opportunities. By connecting claims, structured and unstructured EHR data, laboratory results, social determinants of health (SDOH) and mortality data into a single clinically validated asset, NorstellaLinQ delivers the insights needed to improve […]
Unstructured EHR Data Unmatched Clinical Insights

Norstella transforms unstructured physician notes into longitudinal, analytics-ready data that reveals insights traditional healthcare datasets miss. By combining AI, data curation, and clinical expertise, Norstella helps pharmaceutical teams better understand patient journeys, identify hard-to-find patient populations, optimize HCP engagement and make smarter commercial decisions. Powered by NorstellaLinQ, these insights connect real-time EHR data, claims, lab […]
Find the Right Patient Before the Competition Does

Traditional commercial targeting relies on historical claims and broad provider segments. NorstellaLinQ changes the equation by combining AI-curated clinical data, real-world patient journeys, predictive analytics, and near real-time clinical signals to identify more patients, engage providers earlier, predict what’s next, and coordinate commercial teams around the highest-value opportunities. In this infographic, find out how NorstellaLinQ can help […]
Finding the Right Patients Faster: AI and Real-World Data in Practice

Artificial intelligence is reshaping how life sciences organizations generate evidence, identify patients and make critical decisions—but only when it’s built on trusted, explainable data. In this episode of Real-World Data After Dark, Daniel Chancellor is joined by Norstella’s Kris Kaneta and Ted Search to discuss where AI can create the greatest impact across the pharmaceutical […]
Introducing the Pipeline-to-Patient Productivity Index (P3i)

The P3i is the first benchmark to follow drug performance across the entire development and commercialization lifecycle. It is made possible by Norstella’s unique position across the pharma value chain. The index is designed to support capital allocation and portfolio decisions across biopharma. The report spans the top 25 publicly listed biopharmaceutical companies and provides […]